Literature DB >> 803117

BCG and cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 803117      PMCID： PMC1956607     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Immunity to methylcholanthrene-induced sarcomas.

Authors:  R T PREHN; J M MAIN
Journal:  J Natl Cancer Inst       Date:  1957-06       Impact factor: 13.506

2.  Attempts to induce immunity against mammary adenocarcinoma in inbred mice.

Authors:  E J FOLEY
Journal:  Cancer Res       Date:  1953-08       Impact factor: 12.701

3.  Delay in progression of malignant lymphoma after BCG vaccination.

Authors:  J E Sokal; C W Aungst; M Snyderman
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

Review 4.  BCG and cancer.

Authors:  R C Bast; B Zbar; T Borsos; H J Rapp
Journal:  N Engl J Med       Date:  1974-06-27       Impact factor: 91.245

5.  Results of administering B.C.G. to patients with melanoma.

Authors:  R M Grant; R Mackie; A J Cochran; E L Murray; D Hoyle; C Ross
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

6.  B.C.G. vaccination and leukemia mortality.

Authors:  L Davignon; P Robillard; P Lemonde; A Frappier
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

7.  BCG vaccination and leukemia mortality.

Authors:  S R Rosenthal; R G Crispen; M G Thorne; N Piekarski; N Raisys; P G Rettig
Journal:  JAMA       Date:  1972-12-18       Impact factor: 56.272

8.  Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

Authors:  J U Gutterman; E M Hersh; V Rodriguez; K B McCredie; G Mavligit; R Reed; M A Burgess; T Smith; E Gehan; G P Bodey; E J Freireich
Journal:  Lancet       Date:  1974-12-14       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.